# US 2022/0054137 A1 · Methods and devices for altering lung volume

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0054137 A1
- Document ID: US20220054137A1
- Status: Published application
- Kind: A1
- Application number: 17/516,749
- Filed: 2021-11-02
- Published: 2022-02-24
- Earliest claimed: 2017-08-29
- Assignees: Covidien LP
- Applicants: Covidien LP
- Inventors: William S. Krimsky
- Web page: https://patentgrep.com/patent/US20220054137A1

## CPC

- A61B 17/1214: {Coils or wires}
- A61B 1/2676: {Bronchoscopes}
- A61B 17/12031: {complete occlusion}
- A61B 17/12036: {partial occlusion}
- A61B 17/12104: {in an air passage}
- A61B 17/12145: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 17/1215: {comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated}
- A61L 31/08: Materials for coatings
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61B 5/08: Measuring devices for evaluating the respiratory organs
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00411: {actuated by application of energy from an energy source outside the body}
- A61B 2017/00809: {Lung operations}
- A61B 2017/00867: {shape memory effect}
- A61B 2017/00884: {enhancing wound closure}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00964: {composite}
- A61B 2017/00995: {having a thin film}
- A61B 2017/1205: {Introduction devices}
- A61B 2034/2051: {Electromagnetic tracking systems}
- A61F 2002/043: {Bronchi}
- A61L 2400/16: Materials with shape-memory or superelastic properties
- A61L 2420/08: Coatings comprising two or more layers
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A medical device and methods for altering lung volume are disclosed. The medical device includes a coil formed of a biodegradable material including a first bioabsorbable material that is configured to deactivate a portion of a lung as the coil degrades. The method includes positioning a first coil adjacent a first target within a patient and permitting the first coil to degenerate such that a first bioabsorbable material deactivates a first portion of a lung. The first coil is formed of a biodegradable material and includes the first bioabsorbable material.

## Claims

### Claim 1

A method of altering lung volume, the method comprising:
positioning a coil adjacent a first target within a patient's lungs to fold an airway of the patient's lungs onto itself, the coil formed of a biodegradable material and including a first bioabsorbable material different than and coated over the biodegradable material;
absorbing the first bioabsorbable material into a first portion of the patient's lungs to cause a local inflammatory response that deactivates the first portion of the patient's lungs; and
non-invasively applying energy to the coil adjacent the first target to degenerate the biodegradable material.

### Claim 2 (depends on 1)

The method according to claim 1, wherein absorbing the first bioabsorbable material occurs after a predetermined amount of time, the coil including a second bioabsorbable material covering the first bioabsorbable material, the second bioabsorbable material dissolving to define the predetermined amount of time.

### Claim 3 (depends on 1)

The method according to claim 1, wherein positioning the coil adjacent the first target includes inserting the coil in a linear configuration, the coil transitioning to a coiled configuration when positioned at the first target.

### Claim at position 4

4-6. (canceled)

### Claim 7 (depends on 1)

The method according to claim 1, further comprising positioning a first valve adjacent a second target within the patient's lungs, the first valve having a closed configuration and an open configuration, in the closed configuration air is permitted to exit a second portion of the patient's lungs and is prevented from entering the second portion of the patient's lungs, in the open configuration air is permitted to enter and exit the second portion of the patient's lungs.

### Claim 8 (depends on 7)

The method according to claim 7, further comprising positioning a second valve adjacent a third target within the patient's lungs, the second valve having a closed configuration and an open configuration, in the closed configuration air is permitted to exit a third portion of the patient's lungs and is prevented from entering the third portion of the patient's lungs, in the open configuration air is permitted to enter and exit the third portion of the patient's lungs.

### Claim 9 (depends on 7)

The method according to claim 7, further comprising transitioning the first valve from the open configuration to the closed configuration from external of the patient.

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12 (depends on 7)

The method according to claim 7, wherein positioning the coil adjacent the first target includes passing the coil through the first valve while the first valve is in the open configuration.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The method according to claim 1, further comprising applying energy from external of the patient to the coil adjacent to the first target to transition the coil from a linear configuration to a coiled configuration.

### Claim 15 (depends on 1)

The method according to claim 1, wherein non-invasively applying energy to the coil adjacent the first target accelerates degeneration of the biodegradable material.

### Claim 16 (depends on 1)

The method according to claim 1, wherein non-invasively applying energy to the coil adjacent the first target includes applying the energy from an energy source located external to the patient.

### Claim 17 (depends on 1)

The method according to claim 1, wherein non-invasively applying energy to the coil adjacent the first target includes heating the biodegradable material.

### Claim 18 (depends on 1)

The method according to claim 1, further comprising exposing the coil to a magnetic field after positioning the coil adjacent the first target to transition the coil from a linear configuration to a coiled configuration to fold the airway of the patient's lungs onto itself.

### Claim 19

A method of altering lung volume, the method comprising:
positioning a coil formed of a biodegradable core material at a target within an airway of a patient's lungs; and
accelerating degeneration of the biodegradable core material at the target by non-invasively applying energy to the biodegradable core material to heat the biodegradable core material.

### Claim 20 (depends on 19)

The method according to claim 19, wherein accelerating degeneration of the biodegradable core material includes non-invasively applying the energy to the biodegradable core material from an energy source located external to the patient.

### Claim 21 (depends on 19)

The method according to claim 19, wherein accelerating degeneration of the biodegradable core material includes non-invasively applying the energy through tissue of the patient.

### Claim 22 (depends on 19)

The method according to claim 19, further comprising absorbing a bioabsorbable material coated over the biodegradable core material of the coil into a portion of the patient's lungs to deactivate the portion of the patient's lungs.

### Claim 23 (depends on 19)

The method according to claim 19, further comprising exposing the coil to a magnetic field after positioning the coil at the target to transition the coil from a linear configuration to a coiled configuration to fold an airway of the patient's lungs onto itself.

### Claim 24

A method of altering lung volume, the method comprising:
positioning a coil formed of a biodegradable core material at a target within an airway of a patient's lungs; and
non-invasively applying energy to the biodegradable core material at the target from an energy source located external to the patient to heat the biodegradable core material.

### Claim 25 (depends on 24)

The method according to claim 24, wherein non-invasively applying energy to the biodegradable core material accelerates degeneration of the biodegradable core material.

### Claim 26 (depends on 24)

The method according to claim 24, further comprising exposing the coil to a magnetic field after positioning the coil at the target to transition the coil from a linear configuration to a coiled configuration to fold an airway of the patient's lungs onto itself.
